Johnson & White Wealth Management, LLC Bristol Myers Squibb CO Transaction History

Johnson & White Wealth Management, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 10, 2024	BUY	$47.98 - $54.4 $125,323 - $142,092	2,612 Added 28.33%	11,833 $642,000
Q4 2023 Jan 17, 2024	SELL	$48.48 - $57.85 $77,471 - $92,444	-1,598 Reduced 14.77%	9,221 $473,000
Q3 2023 Oct 12, 2023	BUY	$57.89 - $64.73 $626,311 - $700,313	10,819 New	10,819 $628,000
Q1 2023 Apr 17, 2023	BUY	$65.71 - $74.53 $684,501 - $776,379	10,417 New	10,417 $722,000
Q3 2022 Nov 14, 2022	BUY	$0.13 - $76.84 $1,382 - $817,193	10,635 New	10,635 $756,000

2,404

1.5B

29.7M

32.2M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $115B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of Johnson & White Wealth Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Johnson & White Wealth Management, LLC with notifications on news.